• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三萜酰胺类化合物的若丹明 101 缀合物与它们的若丹明 B 类似物具有相当的细胞毒性。

Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs.

机构信息

Department of Organic Chemistry, Martin-Luther University Halle-Wittenberg, Kurt-Mothes Str. 2, D-06120 Halle (Saale), Germany.

出版信息

Molecules. 2022 Mar 29;27(7):2220. doi: 10.3390/molecules27072220.

DOI:10.3390/molecules27072220
PMID:35408619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9000871/
Abstract

Pentacyclic triterpenoic acids (betulinic, oleanolic, ursolic, and platanic acid) were selected and subjected to acetylation followed by the formation of amides derived from either piperazine or homopiperazine. These amides were coupled with either rhodamine B or rhodamine 101. All of these compounds were screened for their cytotoxic activity in SRB assays. As a result, the cytotoxicity of the parent acids was low but increased slightly upon their acetylation while a significant increase in cytotoxicity was observed for piperazinyl and homopiperazinyl amides. A tremendous improvement in cytotoxicity was observed; however, for the rhodamine B and rhodamine 101 conjugates, and compound , an ursolic acid derived homopiperazinyl amide holding a rhodamine 101 residue showed an EC = 0.05 µM for A2780 ovarian cancer cells while being less cytotoxic for non-malignant fibroblasts. To date, the rhodamine 101 derivatives presented here are the first examples of triterpene derivatives holding a rhodamine residue different from rhodamine B.

摘要

五环三萜酸(白桦脂酸、齐墩果酸、熊果酸和角鲨烯酸)被选择并进行乙酰化,然后形成哌嗪或高哌嗪衍生的酰胺。这些酰胺与若丹明 B 或罗丹明 101 偶联。所有这些化合物都在 SRB 测定中进行了细胞毒性筛选。结果表明,母体酸的细胞毒性较低,但乙酰化后略有增加,而哌嗪基和高哌嗪基酰胺的细胞毒性显著增加。然而,对于若丹明 B 和罗丹明 101 缀合物以及化合物 ,一种具有罗丹明 101 残基的熊果酸衍生的高哌嗪基酰胺对 A2780 卵巢癌细胞的 EC = 0.05 µM,而对非恶性成纤维细胞的细胞毒性较小。迄今为止,本文所呈现的罗丹明 101 衍生物是首例具有不同于若丹明 B 的罗丹明残基的三萜衍生物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/e630f687d745/molecules-27-02220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/2e18234f3d0a/molecules-27-02220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/3710eb3b1aaf/molecules-27-02220-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/ac27af36c895/molecules-27-02220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/e630f687d745/molecules-27-02220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/2e18234f3d0a/molecules-27-02220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/3710eb3b1aaf/molecules-27-02220-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/ac27af36c895/molecules-27-02220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d0a/9000871/e630f687d745/molecules-27-02220-g003.jpg

相似文献

1
Rhodamine 101 Conjugates of Triterpenoic Amides Are of Comparable Cytotoxicity as Their Rhodamine B Analogs.三萜酰胺类化合物的若丹明 101 缀合物与它们的若丹明 B 类似物具有相当的细胞毒性。
Molecules. 2022 Mar 29;27(7):2220. doi: 10.3390/molecules27072220.
2
Homopiperazine-rhodamine B adducts of triterpenoic acids are strong mitocans.三萜酸同哌嗪罗丹明 B 的加合物是强的线粒体靶向药物。
Eur J Med Chem. 2018 Jul 15;155:869-879. doi: 10.1016/j.ejmech.2018.06.051. Epub 2018 Jun 27.
3
Rhodamine B conjugates of triterpenoic acids are cytotoxic mitocans even at nanomolar concentrations.三萜酸的罗丹明B共轭物即使在纳摩尔浓度下也是具有细胞毒性的线粒体靶向剂。
Eur J Med Chem. 2017 Feb 15;127:1-9. doi: 10.1016/j.ejmech.2016.12.040. Epub 2016 Dec 23.
4
Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity.合成具有增强细胞毒性的洛拉明偶联的羽扇豆烷型三萜。
Molecules. 2024 May 16;29(10):2346. doi: 10.3390/molecules29102346.
5
Developing an Amide-Spacered Triterpenoid Rhodamine Hybrid of Nano-Molar Cytotoxicity Combined with Excellent Tumor Cell/Non-Tumor Cell Selectivity.开发出一种具有纳摩尔细胞毒性的酰胺间隔三萜类罗丹明杂合体,具有优异的肿瘤细胞/非肿瘤细胞选择性。
Molecules. 2023 Sep 1;28(17):6404. doi: 10.3390/molecules28176404.
6
Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.米托卡尼二萜和三萜类罗丹明 B 缀合物。
Molecules. 2020 Nov 20;25(22):5443. doi: 10.3390/molecules25225443.
7
Mitochondria-Targeting 1,5-Diazacyclooctane-Spacered Triterpene Rhodamine Conjugates Exhibit Cytotoxicity at Sub-Nanomolar Concentration against Breast Cancer Cells.线粒体靶向 1,5-二氮杂环辛烷间隔三萜类罗丹明缀合物以亚纳摩尔浓度对乳腺癌细胞表现出细胞毒性。
Int J Mol Sci. 2023 Jun 27;24(13):10695. doi: 10.3390/ijms241310695.
8
Targeting mitochondria: Esters of rhodamine B with triterpenoids are mitocanic triggers of apoptosis.靶向线粒体:具有三萜的罗丹明 B 酯类是细胞凋亡的Mitocanic 触发剂。
Eur J Med Chem. 2018 May 25;152:21-30. doi: 10.1016/j.ejmech.2018.04.031. Epub 2018 Apr 17.
9
Madecassic Acid-A New Scaffold for Highly Cytotoxic Agents.玛蒂酸——一种新型的高细胞毒性药物支架。
Int J Mol Sci. 2022 Apr 14;23(8):4362. doi: 10.3390/ijms23084362.
10
Synthesis and cytotoxicity of betulin and betulinic acid derived 30-oxo-amides.桦木醇和齐墩果酸衍生的 30-氧代酰胺的合成及细胞毒性。
Steroids. 2022 Jun;182:109014. doi: 10.1016/j.steroids.2022.109014. Epub 2022 Mar 18.

引用本文的文献

1
Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity.合成具有增强细胞毒性的洛拉明偶联的羽扇豆烷型三萜。
Molecules. 2024 May 16;29(10):2346. doi: 10.3390/molecules29102346.
2
Developing an Amide-Spacered Triterpenoid Rhodamine Hybrid of Nano-Molar Cytotoxicity Combined with Excellent Tumor Cell/Non-Tumor Cell Selectivity.开发出一种具有纳摩尔细胞毒性的酰胺间隔三萜类罗丹明杂合体,具有优异的肿瘤细胞/非肿瘤细胞选择性。
Molecules. 2023 Sep 1;28(17):6404. doi: 10.3390/molecules28176404.
3
Mitochondria-Targeting 1,5-Diazacyclooctane-Spacered Triterpene Rhodamine Conjugates Exhibit Cytotoxicity at Sub-Nanomolar Concentration against Breast Cancer Cells.

本文引用的文献

1
Type and position of linkage govern the cytotoxicity of oleanolic acid rhodamine B hybrids.键合类型和位置决定了齐墩果酸罗丹明 B 杂化物的细胞毒性。
Steroids. 2021 Aug;172:108876. doi: 10.1016/j.steroids.2021.108876. Epub 2021 Jun 12.
2
The Presence of a Cyclohexyldiamine Moiety Confers Cytotoxicity to Pentacyclic Triterpenoids.环己基二胺部分的存在赋予五环三萜类化合物细胞毒性。
Molecules. 2021 Apr 6;26(7):2102. doi: 10.3390/molecules26072102.
3
Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.米托卡尼二萜和三萜类罗丹明 B 缀合物。
线粒体靶向 1,5-二氮杂环辛烷间隔三萜类罗丹明缀合物以亚纳摩尔浓度对乳腺癌细胞表现出细胞毒性。
Int J Mol Sci. 2023 Jun 27;24(13):10695. doi: 10.3390/ijms241310695.
4
Designing Next-Generation Drug-like Molecules for Medicinal Applications.设计用于药物应用的下一代类药性分子。
Molecules. 2023 Feb 16;28(4):1860. doi: 10.3390/molecules28041860.
5
Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.线粒体遗传和表观遗传调控在癌症中的作用:治疗潜力。
Int J Mol Sci. 2022 Jul 18;23(14):7897. doi: 10.3390/ijms23147897.
6
Targeting Energy Metabolism in Cancer Treatment.靶向癌症治疗中的能量代谢。
Int J Mol Sci. 2022 May 16;23(10):5572. doi: 10.3390/ijms23105572.
Molecules. 2020 Nov 20;25(22):5443. doi: 10.3390/molecules25225443.
4
Novel Mitochondria-targeted Drugs for Cancer Therapy.新型线粒体靶向药物在癌症治疗中的应用
Mini Rev Med Chem. 2021;21(7):816-832. doi: 10.2174/1389557520666201118153242.
5
Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy.重新审视 Mitocans:靶向线粒体的高效抗癌疗法。
Int J Mol Sci. 2020 Oct 26;21(21):7941. doi: 10.3390/ijms21217941.
6
Natural Agents Targeting Mitochondria in Cancer.天然药物靶向作用于肿瘤细胞线粒体的研究进展
Int J Mol Sci. 2020 Sep 23;21(19):6992. doi: 10.3390/ijms21196992.
7
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress.精准医学治疗晚期胃食管腺癌:一项正在进行的工作。
J Clin Med. 2020 Sep 22;9(9):3049. doi: 10.3390/jcm9093049.
8
The presence of a cationic center is not alone decisive for the cytotoxicity of triterpene carboxylic acid amides.三萜羧酸酰胺的细胞毒性不仅仅取决于阳离子中心的存在。
Steroids. 2020 Nov;163:108713. doi: 10.1016/j.steroids.2020.108713. Epub 2020 Aug 12.
9
Synthesis of some steroidal mitocans of nanomolar cytotoxicity acting by apoptosis.一些具有纳米级细胞毒性的甾体米托坎的合成,这些化合物通过细胞凋亡发挥作用。
Eur J Med Chem. 2020 Aug 1;199:112425. doi: 10.1016/j.ejmech.2020.112425. Epub 2020 May 11.
10
Personalized Medicine: Recent Progress in Cancer Therapy.个性化医疗:癌症治疗的最新进展
Cancers (Basel). 2020 Apr 19;12(4):1009. doi: 10.3390/cancers12041009.